+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1lfd | ||||||
---|---|---|---|---|---|---|---|
タイトル | CRYSTAL STRUCTURE OF THE ACTIVE RAS PROTEIN COMPLEXED WITH THE RAS-INTERACTING DOMAIN OF RALGDS | ||||||
![]() |
| ||||||
![]() | COMPLEX (RALGDS/RAS) / COMPLEX (RALGDS-RAS) / RAL / EFFECTOR INTERACTION / COMPLEX (RALGDS-RAS) complex | ||||||
機能・相同性 | ![]() p38MAPK events / GTPase regulator activity / phospholipase C activator activity / GTPase complex / positive regulation of ruffle assembly / oncogene-induced cell senescence / RAF/MAP kinase cascade / negative regulation of GTPase activity / positive regulation of miRNA metabolic process / T-helper 1 type immune response ...p38MAPK events / GTPase regulator activity / phospholipase C activator activity / GTPase complex / positive regulation of ruffle assembly / oncogene-induced cell senescence / RAF/MAP kinase cascade / negative regulation of GTPase activity / positive regulation of miRNA metabolic process / T-helper 1 type immune response / positive regulation of wound healing / regulation of neurotransmitter receptor localization to postsynaptic specialization membrane / small GTPase-mediated signal transduction / defense response to protozoan / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / brush border / RAS signaling downstream of NF1 loss-of-function variants / SOS-mediated signalling / Activated NTRK3 signals through RAS / positive regulation of protein targeting to membrane / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / Signalling to RAS / adipose tissue development / Activated NTRK2 signals through FRS2 and FRS3 / SHC-related events triggered by IGF1R / Estrogen-stimulated signaling through PRKCZ / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / Schwann cell development / SHC-mediated cascade:FGFR2 / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / SHC-mediated cascade:FGFR4 / Signaling by FGFR4 in disease / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / protein-membrane adaptor activity / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / p38MAPK events / Tie2 Signaling / FRS-mediated FGFR1 signaling / Signaling by FGFR2 in disease / GRB2 events in EGFR signaling / SHC1 events in EGFR signaling / EPHB-mediated forward signaling / Signaling by FLT3 fusion proteins / FLT3 Signaling / Signaling by FGFR1 in disease / myelination / EGFR Transactivation by Gastrin / positive regulation of GTPase activity / NCAM signaling for neurite out-growth / CD209 (DC-SIGN) signaling / positive regulation of MAP kinase activity / GRB2 events in ERBB2 signaling / Downstream signal transduction / Ras activation upon Ca2+ influx through NMDA receptor / SHC1 events in ERBB2 signaling / Insulin receptor signalling cascade / intrinsic apoptotic signaling pathway / Constitutive Signaling by Overexpressed ERBB2 / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / guanyl-nucleotide exchange factor activity / VEGFR2 mediated cell proliferation / positive regulation of epithelial cell proliferation / small monomeric GTPase / animal organ morphogenesis / regulation of actin cytoskeleton organization / FCERI mediated MAPK activation / positive regulation of JNK cascade / RAF activation / regulation of long-term neuronal synaptic plasticity / Signaling by ERBB2 TMD/JMD mutants / Signaling by high-kinase activity BRAF mutants / Signaling by SCF-KIT / Constitutive Signaling by EGFRvIII / MAP2K and MAPK activation / cellular response to gamma radiation / Signaling by ERBB2 ECD mutants / Signaling by ERBB2 KD Mutants / positive regulation of type II interferon production / positive regulation of fibroblast proliferation / endocytosis / Regulation of RAS by GAPs / RAS processing / chemotaxis / Signaling by RAF1 mutants / Negative regulation of MAPK pathway / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / GDP binding 類似検索 - 分子機能 | ||||||
生物種 | ![]() ![]() ![]() | ||||||
手法 | ![]() ![]() ![]() | ||||||
![]() | Huang, L. / Hofer, F. / Martin, G.S. / Kim, S.-H. | ||||||
![]() | ![]() タイトル: Structural basis for the interaction of Ras with RalGDS. 著者: Huang, L. / Hofer, F. / Martin, G.S. / Kim, S.H. #1: ![]() タイトル: Three-Dimensional Structure of the Ras-Interacting Domain of Ralgds 著者: Huang, L. / Weng, X. / Hofer, F. / Martin, G.S. / Kim, S.H. #2: ![]() タイトル: Erratum. Three-Dimensional Structure of the Ras-Interacting Domain of Ralgds 著者: Huang, L. / Weng, X. / Hofer, F. / Martin, G.S. / Kim, S.H. #3: ![]() タイトル: Activated Ras Interacts with the Ral Guanine Nucleotide Dissociation Stimulator 著者: Hofer, F. / Fields, S. / Schneider, C. / Martin, G.S. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 122.2 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 93.9 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
---|
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| ||||||||||||
2 | ![]()
| ||||||||||||
単位格子 |
| ||||||||||||
非結晶学的対称性 (NCS) | NCS oper:
|
-
要素
#1: タンパク質 | 分子量: 9989.313 Da / 分子数: 2 / 断片: RAS-INTERACTING DOMAIN, C-TERMINAL DOMAIN / 由来タイプ: 組換発現 / 詳細: BINDS TO ACTIVE HUMAN RAS / 由来: (組換発現) ![]() ![]() 遺伝子 (発現宿主): C-TERMINAL DOMAIN OF RAT RALGDSB (RESIDUES 767-864) FUSED TO GST PROTEIN 発現宿主: ![]() ![]() #2: タンパク質 | 分子量: 19004.438 Da / 分子数: 2 / 断片: RESIDUES 1-171 / Mutation: E31K / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() ![]() #3: 化合物 | #4: 化合物 | #5: 水 | ChemComp-HOH / | |
---|
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 2.17 Å3/Da / 溶媒含有率: 50 % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | pH: 6.5 / 詳細: pH 6.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
結晶化 | *PLUS pH: 7.5 / 手法: 蒸気拡散法, ハンギングドロップ法 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
回折 | 平均測定温度: 92 K |
---|---|
放射光源 | 由来: ![]() ![]() ![]() |
検出器 | 日付: 1997年9月1日 |
放射 | 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.1 Å / 相対比: 1 |
反射 | 解像度: 2.1→15 Å / Num. obs: 30504 / % possible obs: 98.3 % / Observed criterion σ(I): 2 / 冗長度: 4.2 % / Biso Wilson estimate: 20 Å2 / Rmerge(I) obs: 0.061 / Rsym value: 0.061 / Net I/σ(I): 24.5 |
反射 シェル | 解像度: 2.1→2.18 Å / 冗長度: 4 % / Rmerge(I) obs: 0.061 / Mean I/σ(I) obs: 5.7 / Rsym value: 0.268 / % possible all: 97.5 |
反射 | *PLUS Num. measured all: 129387 |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]() 開始モデル: PDB ENTRY 1LXD, 6Q21 解像度: 2.1→6 Å / Data cutoff high absF: 10000000 / Data cutoff low absF: 0 / 交差検証法: THROUGHOUT / σ(F): 2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 15 Å2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.1→6 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refine LS restraints NCS | NCS model details: NO NCS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: ![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 | *PLUS
|